Classification | Target | Prediction |
---|---|---|
Toxicity end points | Carcinogenicity | Inactive |
Toxicity end points | Mutagenicity | Inactive |
Toxicity end points | Cytotoxicity | Inactive |
Tox21-nuclear receptor signalling pathways | Aryl hydrocarbon Receptor (AhR) | Inactive |
Tox21-nuclear receptor signalling pathways | Androgen Receptor (AR) | Inactive |
Tox21-nuclear receptor signalling pathways | Androgen Receptor Ligand Binding Domain (AR-LBD) | Inactive |
Tox21-nuclear receptor signalling pathways | Peroxisome Proliferator Activated Receptor Gamma (PPAR-Gamma) | Inactive |
Tox21-stress response pathways | Nuclear factor (erythroid-derived 2)-like 2/antioxidant responsive element (nrf2/ARE) | Inactive |
Tox21-stress response pathways | Heat shock factor response element (HSE) | Inactive |
Tox21-stress response pathways | Mitochondrial Membrane Potential (MMP) | Inactive |
Tox21-stress response pathways | Phosphoprotein (Tumor Supressor) p53 | Inactive |
Tox21-stress response pathways | ATPase family AAA domain-containing protein 5 (ATAD5) | Inactive |